Supplier Type
- Manufacturer
- Trader
- contract manufacturer
- Reagent
Supplier Region
- Maharashtra(11)
- Gujarat(16)
- Hyderabad(10)
- Ahmedabad(6)
- Bangalore(1)
- New Delhi(1)
- Delhi(4)
- Mumbai(19)
- Vadodara(4)
- Pune(2)
- Haryana(1)
- Telangana(2)
- Madhya Pradesh(1)
- Karnataka(1)
Purity
- Salicylic Acid
- NLT 95%
- more than 90%
- Min. 80%
- Mesalazine EP Impurity H
- Greater than 99%
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.55%
- >99.5%
- 99.00%
- 99% Minimum
- > 99%
- 99%
- >99%
- 98.66%
- 98%
- 97-99%
- 97.84%
- 97%
- 96.40%
- 96.13%
- 96.00 % Min
- 96%
- 95.00%
- 95.00 % Min
- >95%
- 94%
- 93.0 % Min
- >92%
- 90-95%
- 90%
- >90%
- 90 % Min.
- 90 % Above
- 86.74%
- 68.0 % Min
- 65%
- 25 MG 50 MG 100 MG 250 MG EXTRA
Package
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1000mg
- 1gm
- 1kg
- 5kg
- 25kg
- 500kg
- 1MT
- 250250 mg.
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 10kg
- 100kg
- 1and gm
- 95NLT %
-
SalMeterol Xinafoate Adduct IMpurity
1330076-52-2
-
(S)-Duloxetine SuccinaMide
199191-66-7
-
2-(2H-Benzotriazol-2-yl)-p-cresol
612069-30-4
-
1(2H)-Pyridinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-3,4-dihydro-, ethyl ester
2470226-18-5
-
Atorvastatin lactone
125995-03-1
-
Aspartame
7421-84-3
-
SODIUM ALUMINUM SULFATE
10102-71-3
-
Povidone iodine
25655-41-8
-
Tetrasodium pyrophosphate
7722-88-5
-
Stearic acid
57-11-4
Salmeterol USP Related Compound H 1330076-52-2
DULOXETINE USP RELATED COMPOUND H 199191-66-7
Aspartame 7421-84-3
Lidocaine hydrochloride 73-78-9
Lidocaine hydrochloride 73-78-9
Lidocaine hydrochloride 73-78-9
Lidocaine hydrochloride 73-78-9
Levothyroxine impurity H (T4 benzocic acid) 2055-97-2